US7048906B2
(en)
|
1995-05-17 |
2006-05-23 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
|
US6861053B1
(en)
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
US7078399B2
(en)
*
|
2001-12-13 |
2006-07-18 |
Activbiotics, Inc. |
Sulfhydryl rifamycins and uses thereof
|
ITMI20032144A1
(it)
*
|
2003-11-07 |
2005-05-08 |
Alfa Wassermann Spa |
Forme polimorfe di rifaximina, processi per ottenerle e
|
US20080262024A1
(en)
*
|
2003-11-07 |
2008-10-23 |
Giuseppe Claudio Viscomi |
Rifaximin compositions and method of use
|
US7923553B2
(en)
|
2003-11-07 |
2011-04-12 |
Alfa Wassermann, S.P.A. |
Processes for the production of polymorphic forms of rifaximin
|
US7902206B2
(en)
|
2003-11-07 |
2011-03-08 |
Alfa Wassermann, S.P.A. |
Polymorphic forms α, β and γ of rifaximin
|
US7906542B2
(en)
|
2004-11-04 |
2011-03-15 |
Alfa Wassermann, S.P.A. |
Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
|
US20060210492A1
(en)
*
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Use of rifaximin for treatment and prevention of periodontal conditions
|
US8003118B2
(en)
*
|
2005-03-02 |
2011-08-23 |
Kodsi Robert E |
Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
|
US20060210483A1
(en)
*
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
|
DK1698630T3
(da)
*
|
2005-03-03 |
2014-12-08 |
Alfa Wassermann Spa |
Nye polymorfe former af rifaximin, fremgangsmåde for deres fremstilling og anvendelse deraf i de medicinske præparater
|
ITBO20050123A1
(it)
*
|
2005-03-07 |
2005-06-06 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
|
ES2747259T3
(es)
|
2006-03-09 |
2020-03-10 |
Salix Pharmaceuticals Inc |
Preparación anti-disfunción rectal de rifaximina
|
CA2659874C
(en)
|
2006-08-02 |
2016-10-11 |
Salix Pharmaceuticals, Inc. |
Methods for the treatment of radiation proctosigmoiditis
|
ITMI20061692A1
(it)
|
2006-09-05 |
2008-03-06 |
Alfa Wassermann Spa |
Uso di polioli per ottenere forme polimorfe stabili di rifaximina
|
EP2069363B1
(en)
*
|
2006-09-22 |
2013-03-20 |
Cipla Ltd. |
Rifaximin in an amorphous form
|
US20080161337A1
(en)
*
|
2007-01-03 |
2008-07-03 |
Leonard Weinstock |
Use of Rifaximin for the Treatment of Chronic Prostatitis
|
US20080159987A1
(en)
*
|
2007-01-03 |
2008-07-03 |
Leonard Weinstock |
Use of Rifaximin for the Treatment of Restless Legs Syndrome
|
ITMI20071241A1
(it)
*
|
2007-06-20 |
2008-12-21 |
Solmag S P A |
Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
|
US7709634B2
(en)
|
2007-09-20 |
2010-05-04 |
Apotex Pharmachem Inc. |
Amorphous form of rifaximin and processes for its preparation
|
US8486956B2
(en)
|
2008-02-25 |
2013-07-16 |
Salix Pharmaceuticals, Ltd |
Forms of rifaximin and uses thereof
|
CN102015725B
(zh)
|
2008-02-25 |
2014-10-22 |
萨利克斯药品有限公司 |
利福昔明的多种形式及其用途
|
PL2252148T3
(pl)
|
2008-02-26 |
2019-09-30 |
Salix Pharmaceuticals, Ltd. |
Sposoby leczenia zespołu jelita drażliwego
|
US11779571B2
(en)
|
2008-02-26 |
2023-10-10 |
Salix Pharmaceuticals, Inc. |
Methods for treating irritable bowel syndrome (IBS)
|
DK2294012T3
(da)
|
2008-05-07 |
2014-10-06 |
Salix Pharmaceuticals Ltd |
Administration af et tarmrensemiddel og et antibiotika til behandlingen af tarmsygdom
|
CN101585843B
(zh)
*
|
2008-05-21 |
2011-07-06 |
重庆赛诺生物药业股份有限公司 |
一种利福昔明的制备工艺
|
SI3628319T1
(sl)
|
2008-10-02 |
2024-04-30 |
Salix Pharmaceuticals, Ltd. |
Zdravljenje jetrne encefalopatije z rifaksiminom
|
US20110035232A1
(en)
|
2008-10-02 |
2011-02-10 |
Salix Pharmaceuticals, Ltd. |
Methods of treating hepatic encephalopathy
|
US7928115B2
(en)
|
2008-10-02 |
2011-04-19 |
Salix Pharmaceuticals, Ltd. |
Methods of treating travelers diarrhea and hepatic encephalopathy
|
JP5756020B2
(ja)
|
2008-12-10 |
2015-07-29 |
シプラ・リミテッド |
リファキシミン複合体
|
IT1397617B1
(it)
*
|
2009-04-20 |
2013-01-18 |
Alfa Wassermann Spa |
Nuovi derivati della rifamicina
|
NZ596851A
(en)
|
2009-06-02 |
2013-10-25 |
Salix Pharmaceuticals Ltd |
Methods of treating hepatic encephalopathy
|
KR20120062897A
(ko)
|
2009-09-13 |
2012-06-14 |
샐릭스 파마슈티컬스 리미티드 |
과민성 장 증후군(ibs)의 치료방법
|
BR112012012316A2
(pt)
|
2009-11-23 |
2016-04-26 |
Cipla Ltd |
composição farmacêutica para administração retal tópica na forma de espuma, uso de uma composição farmacêutica, método para tratamento, prevenção ou alívio de um dustúrbio no reto, cólon, íleo terminal ou ânus, processo para fabricação de uma composição farmacêutica contendo rifaximina, uso de um silicone e dispensador para composição farmacêutica
|
WO2011080691A1
(en)
|
2009-12-28 |
2011-07-07 |
Silvio Massimo Lavagna |
Method for the production of amorphous rifaximin
|
AU2011218129A1
(en)
|
2010-02-18 |
2012-08-23 |
Board Of Regents Of The University Of Texas System |
Methods for treating infection
|
IT1398550B1
(it)
|
2010-03-05 |
2013-03-01 |
Alfa Wassermann Spa |
Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
|
WO2011156897A2
(en)
*
|
2010-06-16 |
2011-12-22 |
Apotex Pharmachem Inc. |
Polymorphic forms of rifaximin
|
CN103228662B
(zh)
|
2010-07-12 |
2016-08-10 |
萨利克斯药品有限公司 |
利福昔明的制剂及其用途
|
US8759513B2
(en)
|
2010-09-13 |
2014-06-24 |
Sequent Scientific Limited |
Polymorphic form of rifaximin and process for its preparation
|
US8735419B2
(en)
|
2011-02-11 |
2014-05-27 |
Salix Pharmaceuticals, Ltd. |
Forms of rifaximin and uses thereof
|
CA2834829A1
(en)
|
2011-05-02 |
2012-11-08 |
Ranbaxy Laboratories Limited |
Rifaximin dimethylformamide solvate
|
WO2012155981A1
(en)
|
2011-05-19 |
2012-11-22 |
Friulchem Spa |
New process for the synthesis of rifaximin and a new pseudo-crystalline form of rifaximin obtained thereby
|
ITBO20110461A1
(it)
|
2011-07-29 |
2013-01-30 |
Alfa Wassermann Spa |
Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
|
AU2012332211B2
(en)
|
2011-11-02 |
2016-11-24 |
Salix Pharmaceuticals, Ltd. |
Methods for treating irritable bowel syndrome (IBS) and infections
|
US9359374B2
(en)
|
2012-06-13 |
2016-06-07 |
Apotex Pharmachem Inc. |
Polymorphic forms of rifaximin
|
ITBO20120368A1
(it)
|
2012-07-06 |
2014-01-07 |
Alfa Wassermann Spa |
Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
|
US20160038468A1
(en)
|
2013-03-15 |
2016-02-11 |
Alfa Wassermann S.P.A. |
Rifaximin for use in the treating of vaginal infections
|
EP2971062A2
(en)
|
2013-03-15 |
2016-01-20 |
ALFA WASSERMANN S.p.A. |
Method for diagnosing vaginal infections
|
JP6433980B2
(ja)
|
2013-04-12 |
2018-12-05 |
アルファシグマ ソシエタ ペル アチオニ |
Nsaid投与並びに関連する組成物、方法及びシステム
|
US9018225B1
(en)
|
2013-07-26 |
2015-04-28 |
Novel Laboratories |
Rifaximin crystalline forms and methods of preparation thereof
|
ITMI20131307A1
(it)
|
2013-08-02 |
2015-02-02 |
A M S A Anonima Materie Sint & Affini S P A |
Processo per la preparazione di refaximina k
|
CN103509038B
(zh)
*
|
2013-09-30 |
2016-01-20 |
浙江思贤制药有限公司 |
一种新晶型利福昔明ζ及其制备方法
|
ES2621557T3
(es)
|
2014-03-31 |
2017-07-04 |
Euticals S.P.A. |
Mezcla polimórfica de rifaximina y su uso para la preparación de formulaciones sólidas
|
CA2947962C
(en)
|
2014-05-04 |
2024-01-16 |
Salix Pharmaceuticals, Inc. |
Ibs microbiota and uses thereof
|
ES2742106T3
(es)
|
2014-05-12 |
2020-02-13 |
Alfasigma Spa |
Nueva forma de cristal solvatado de rifaximina, producción, composiciones y usos de la misma
|
EP2982764A1
(en)
|
2014-08-05 |
2016-02-10 |
ALFA WASSERMANN S.p.A. |
Identification of vaginal bacteria
|
US9988398B2
(en)
|
2016-06-07 |
2018-06-05 |
Cadila Healthcare Limited |
Crystalline form of rifaximin and process for its preparation
|
WO2018064472A1
(en)
|
2016-09-30 |
2018-04-05 |
Salix Pharmaceuticals, Ltd. |
Solid dispersion forms of rifaximin
|
PL3645539T3
(pl)
*
|
2017-06-26 |
2021-10-25 |
Biofer S.P.A. |
Pochodne pirydoimidazoryfamycyny jako środek przeciwbakteryjny
|